Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients.
about
Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical RelevanceChallenges in the clinical utility of the serum test for HER2 ECDThe knowledge-integrated network biomarkers discovery for major adverse cardiac eventsInterference-Free HER2 ECD as a Serum Biomarker in Breast Cancer.Discovery and validation of breast cancer early detection biomarkers in preclinical samplesSerum HER 2 extracellular domain level is correlated with tissue HER 2 status in metastatic gastric or gastro-oesophageal junction adenocarcinomaHighly sensitive detection of HER2 extracellular domain in the serum of breast cancer patients by piezoelectric microcantilevers.Preoperative serum HER2 extracellular domain levels in primary invasive breast cancerAntibody quantum dot conjugates developed via copper-free click chemistry for rapid analysis of biological samples using a microfluidic microsphere array systemEpidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes.Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer.Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidenceTargeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletionLong-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.Evaluation of HER2/neu oncoprotein in serum & tissue samples of women with breast cancer.Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy.Quantitative proteomics of breast tumors: Tissue quality assessment to clinical biomarkers.A highly efficient colorimetric immunoassay using a nanocomposite entrapping magnetic and platinum nanoparticles in ordered mesoporous carbon.A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.Quantification of Breast Cancer Protein Biomarkers at Different Expression Levels in Human Tumors.Analysis of blood markers for early breast cancer diagnosis.Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer.Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.Evaluation of serum HER2-ECD levels in patients with gastric cancer.CA 15-3 serum levels in patients with ductal breast carcinoma: relationship with clinicopathological parameters and tumor markers.Recent Research Trends and Future Prospects in Nanozymes
P2860
Q26750970-A9458992-8489-4A98-9E13-162D53F74A2DQ26861754-82A0754C-E442-4EB6-9245-016D954DC271Q33789038-8D8E5A2C-BB62-4AA8-807E-AA3868CEDDD0Q33966430-567A34E6-6CBF-45B1-9350-20AB53230FFEQ34200678-0D621774-D091-44C5-A501-1C3EB8A76987Q34730478-7C524CA0-F9CE-4225-9D6F-348851A60D69Q34890107-A2AF9D63-6E18-40F9-AE3E-9C6A6CA3964EQ34967515-396AB079-A7A4-408C-8D4C-4F97CE7554A4Q35226001-58C729B4-FEC4-4A6F-859B-27F1A151A046Q36010700-DA52F37B-478E-4D3A-A868-A919479E9036Q36088722-0C88BA5F-E84E-49E4-8AA7-0CE5A098563AQ36250585-13B2272C-48CF-4854-9BD7-2BA909512E9BQ37069906-71AA8994-49ED-465D-8D43-7F641B29CE4CQ37341145-4F666BC0-999F-41FD-AB8D-8179B02FEFC8Q37367705-FFBB4E32-B12D-40D9-9239-7017E21D7124Q37690917-41E3E4D8-DA12-4771-BDD0-AF011A1673EBQ38719192-27ABDB5A-B00D-4B8E-A64D-C9875A0B7A4CQ42285462-303C25BB-7EE5-461F-8F21-8D6E7B61A62EQ42448688-AA73F276-2E45-4431-BC31-C3760656150DQ47130842-B36F9186-337E-46BF-9133-A52B7794BE74Q47291460-39B76C13-7D49-465A-8EF0-DD84D754E3D6Q47725879-234DD2CC-BA7E-4A16-947E-A59111CA1CBDQ47985329-5DB954D3-4B2F-4466-B3E4-FE09AD812B96Q48149731-09EB0EFC-8B9F-44AC-A253-2CA103A3CA05Q54375870-B613B127-C3D7-40F7-9E07-C73F96E8F661Q54559227-BBE7FE27-BD24-4FF8-9656-A6942E715A33Q59114029-0B0E6AEB-3459-456A-92AF-F90B87684736
P2860
Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Serum epidermal growth factor ...... static breast cancer patients.
@ast
Serum epidermal growth factor ...... static breast cancer patients.
@en
type
label
Serum epidermal growth factor ...... static breast cancer patients.
@ast
Serum epidermal growth factor ...... static breast cancer patients.
@en
prefLabel
Serum epidermal growth factor ...... static breast cancer patients.
@ast
Serum epidermal growth factor ...... static breast cancer patients.
@en
P2093
P2860
P356
P1476
Serum epidermal growth factor ...... static breast cancer patients.
@en
P2093
Amit Agrawal
Anthony Hitch
Caroline Chapman
Claire Allen
John F R Robertson
Kristjan S Asgeirsson
Kwok L Cheung
P2860
P2888
P356
10.1186/BCR1788
P50
P577
2007-01-01T00:00:00Z
P5875
P6179
1025009600